Get started
Author

Olga Anagnostou

Observed names: Anagnostou Olga, O Anagnostou, O. Anagnostou, Όλγα Αναγνώστου
ORCID: 0000-0002-0204-9030
Observed ORCID: 0000-0002-0204-9030
OpenAlex ID: A5050785861
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
2019 · Richard T Davey, Eduardo Fernández-Cruz, et al. · The Lancet Respiratory Medicine · 131
PDF
Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high‐prevalence setting?
2017 · Ilias Gountas, Vana Sypsa, et al. · Addiction · 50
Barriers to health care services for migrants living with HIV in Spain
2017 · Patricia Ndumbi, J del Romero, et al. · European Journal of Public Health · 44
PDF
Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study.
2011 · M Raptopoulou, G Touloumi, et al. · PubMed · 35
Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C
2010 · Spilios Manolakopoulos, Melanie J. Deutsch, et al. · Liver International · 27
The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis
2018 · Álvaro H Borges, Jacqueline Neuhaus, et al. · The Journal of Infectious Diseases · 21
PDF
Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study
2017 · Sarah L Pett, Ken M Kunisaki, et al. · Open Forum Infectious Diseases · 21
PDF
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015
2017 · Dominic E Dwyer, Ruth Lynfield, et al. · Open Forum Infectious Diseases · 18
PDF
Design and Development of a Viral Hepatitis and HIV Infection Screening Program (Hprolipsis) for the General, Greek Roma, and Migrant Populations of Greece: Protocol for Three Cross-Sectional Health Examination Surveys
2019 · Giota Touloumi, Argiro Karakosta, et al. · JMIR Research Protocols · 15
PDF
A hepatitis C outbreak preceded the HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study
2019 · Ilias Gountas, Vana Sypsa, et al. · Journal of Viral Hepatitis · 12
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial
2019 · Laura Dickinson, Rohan Gurjar, et al. · Journal of Antimicrobial Chemotherapy · 9
PDF
Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon‐alpha and ribavirin
2013 · A. Striki, S. Manolakopoulos, et al. · Journal of Viral Hepatitis · 9
Treatment cascade of hepatitis B and C in general, migrant and Roma populations
2017 · G. Touloumi, A. Karakosta, et al. · Journal of Hepatology · 7
Factors associated with HCV test uptake in heroin users entering substitution treatment in Greece
2018 · O Anagnostou, A Fotiou, et al. · HIV Medicine · 6
PDF
Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study.
2014 · O Anagnostou, S Manolakopoulos, et al. · Europe PMC (PubMed Central) · 6
Peginterferon/ribavirin treatment achieves a higher compliance rate than interferon/ribavirin combination in patients chronically infected with HCV on methadone maintenance
2009 · Dimitrios Dimitroulopoulos, Elefteria Petroulaki, et al. · European Journal of Gastroenterology & Hepatology · 5
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV
2023 · David M. MacDonald, Sarah Samorodnitsky, et al. · Scientific Reports · 3
PDF
Health Needs and Access to Healthcare Services in Migrant Populations in Greece: Data From the Hprolipsis Study
2025 · Olga Anagnostou, Natassa Kalpourtzi, et al. · Cureus · 2
PDF
1354 Hepatitis C Virus Reinfection Following Sustained Virological Response in Intravenous Drug Users
2012 · S. Manolakopoulos, H. Kranidioti, et al. · Journal of Hepatology · 2
Assessing the impact of COVID-19 pandemic in vulnerable social groups in Athens, Greece
2021 · S Roussos, O Anagnostou, et al. · European Journal of Public Health · 1
PDF
Tu1506 – Adherence to Follow-Up of People Who Inject Drugs (PWID) After the Successful Treatment of Chronic Hepatitis C with Direct-Acting Antivirals (DAA)
2019 · KANELLOS-RAFAIL KOUSTENIS, EVANGELIA KOUTLI, et al. · Gastroenterology · 1
P1251 : Hepatitis B and C: Knowledge, attitudes and preventive practices of the Greek general adult population. Preliminary results of the Greek national health examination survey “Hprolipsis”
2015 · A. Karakosta, V. Sypsa, et al. · Journal of Hepatology · 1
S1013 Drug Users with Chronic Hepatitis C Who Are Adherent to Antiviral Treatment Will Finally Benefit from Therapy
2008 · Olga Anagnostou, Spilios Manolakopoulos, et al. · Gastroenterology · 1
[644] Hepatic Steatosis Predicts Outcome of Chronic Hepatitis C Therapy With Peg-interferon Plus Ribavirin, Independently of Genotype or Bmi but in Correlation to Insulin Resistance (homa-ir)
2007 · S. Savvidou, J. Goulis, et al. · Journal of Hepatology · 1
Design and development of an automated surveillance system for outbreak detection and individual risk assessment for HIV and viral hepatitis B and C among people who use drugs: The Hippocrates project
2026 · Giota Touloumi, Valia Baralou, et al. · International Journal of Drug Policy
Works count: 38
Citation count: 428
H-index: 10
I10-index: 10
Year
Topic
Type